Long‐Lasting Stabilization and Improvement of Dry Age‐Related Macular Degeneration by a High Oral Taurine Dose
Journal Title: Journal of Ophthalmology and Advance Research - Year 2023, Vol 4, Issue 3
Abstract
Purpose: To examine the therapeutic potential of the amino acid taurine in the non‐ neovascular or ∙dry” form of Age‐Related Macular Degeneration (AMD), one of the main causes of vision loss in the elderly, which still lacks effective treatments. Taurine is the most abundant amino acid in the retina and exerts trophic and neuroprotective actions in cellular and animal models. Likewise, a recent Science paper indicates that taurine deficiency is a driver of aging and that taurine supplementation may be an effective treatment for age‐related diseases. Case Description: A dry AMD patient (F.A., male, 62‐yr old) presented a Snellen best corrected visual acuity of 0.15 on the Right Eye (RE) and 0.2 on the Left Eye (LE) in June 2013, together with central retina atrophy and reduction of central macular thickness to 144 µm (RE) and 159 µn (LE) (OCT analysis; Topcon 3D OCT1000). Oral taurine intake (600 mg t.i.d.) arrested macular degeneration over a 5.5‐yr period and moderately improved visual acuity and macular thickness after doubling the dose from 1.8 g/day to 3.6 g/day in December 2018. This improvement remained stable until last control visit in January 2023. Conclusion: Taurine may have disease‐modifying properties in dry AMD at the dose used. The present observations add to existing literature to foster proof‐of‐concept clinical trials using a high oral dose of taurine for the treatment of AMD.
Authors and Affiliations
Juan Cano Parra, Francesc Artigas
Keywords
Related Articles
- EP ID EP723169
- DOI https://doi.org/10.46889/JOAR.2023.4306
- Views 39
- Downloads 0
Following Editor’s Steps in Ophthalmology and Advance Research before the End of 2021
2021 has already been coming to the end when I am writing this in the 4th quarter, and Christmas is on the way. With the COVID-19 pandemic continuously hoisted throughout 2021, most of the academic conferences were tur...
Cosmetic Laser Related Retinal Injuries
Cosmetic industries are booming in many Asian cities where the uptake of laser treatment is becoming more frequent. The close proximity of the cosmetic laser handheld probe to the ocular adnexa is at risk of jeopardizi...
Correlation Between Primary Open Angle Glaucoma and Serum Lipids
Background: Glaucoma is one of the leading causes of blindness worldwide, with Intraocular Pressure (IOP) being the primary risk factor. However, some cases of glaucoma progress even with controlled IOP. This indicates t...
Oily Multifocal IOL
A 58 year old male operated for cataract surgery implanted with a multifocal Intraocular Lens (IOL), later underwent vitreoretinal surgery for retinal detachment with silicone oil injection. Even after removal of silic...
Outcome of Immediate Management in Chemical Ocular Burns
Purpose: To evaluate the outcome of immediate management in acute ocular chemical burns. Methods: 29 eyes of 19 patients with acute chemical burns were studied. All patients received immediate first aid. Limbal and con...